Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 19:7:273.
doi: 10.3389/fvets.2020.00273. eCollection 2020.

Assessment of Circulating Immune Complexes During Natural and Experimental Canine Leishmaniasis

Affiliations

Assessment of Circulating Immune Complexes During Natural and Experimental Canine Leishmaniasis

Manuela Gizzarelli et al. Front Vet Sci. .

Abstract

Canine leishmaniasis (CanL) is a disease characterized by a large variety of clinical alterations, the majority of which being due to immune mediated mechanisms. Sick dogs usually produce high levels of Leishmania-specific immunoglobulins which may give rise to circulating immune complexes (CICs) whose defective clearance by scavenging macrophages induces vasculitis and their deposition in specific organs. The aim of this study was to assess the serum level of CICs in dogs exposed to natural and experimental infection. Fifty-two sera were examined, belonging to untreated groups of naïve beagles previously studied to assess the performance of anti-leishmanial vaccines under natural (no. 22 dogs) or experimental (no. 30 dogs) transmission. Sera were classified in five groups according to the dog's health condition, IFAT titer, and the bone marrow (BM) nested (n)-PCR result. A: no.10 healthy dogs before the experimental infection; B: no.10 clinically healthy dogs infected experimentally, IFAT negative (= reciprocal titer <160) and n-PCR positive; C: no.10 clinically healthy dogs naturally infected, IFAT positive at titers 160-320 and n-PCR negative; D: no.10 sick dogs experimentally infected, IFAT positive at titer >320 and n-PCR positive; E: no.12 sick dogs naturally infected, IFAT positive at titer >320 and n-PCR positive. CICs levels were assessed by ELISA method (canine CIC assay-Cloude-Clone Corporation, USA). The two groups characterized by negative IFAT (A and B) had the lowest median level of CICs (16.09 and 12.78 μg/ml, respectively). CICs value increased progressively in the group C and reached the highest levels in the groups D and E, both characterized by high antibodies titer and severe disease, independently from the mode of infection. Significant differences in CICs concentration (p < 0.0001) were demonstrated between A, B, and C groups when compared with D or E groups of dogs. No differences were found inside the first three groups, while differences were recorded between the last two groups of sick dogs. CICs serum concentration increased with the progress of leishmaniasis, being significantly correlated with the increase of specific antibodies over time. High CICs levels detectable by commercial ELISA proved specific to an established Leishmania infection in dogs in the absence of other concomitant infections, as demonstrated by the similar trend assessed in experimentally and naturally infected dogs.

Keywords: dog; experimental infection; immune complex; leishmaniasis; natural infection.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Graphical representation of CICs serum level.
Figure 1
Figure 1
(A) Correlation between IFAT titers and CICs levels in sera from 52 non-infected or Leishmania infantum-infected beagles; (B) CICs serum levels (median ± SD) in five groups of beagles classified by negative condition or by Leishmania infantum infection characterized by different serological and parasitological parameters. EI, experimental infection; NI, natural infection.

References

    1. Moreno J, Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol. (2002) 18:399–405. 10.1016/S1471-4922(02)02347-4 - DOI - PubMed
    1. Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L. Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. (2008) 24:324–30. 10.1016/j.pt.2008.04.001 - DOI - PubMed
    1. Baneth G, Solano-Gallego L. Leishmaniases. In: Greene CE. editor. Infectious Diseases of the Dog and Cat, 4th edition (St. Louis. MI: Saunders Elsevier; ). (2012). p. 734–49.
    1. Vamvakidis CD, Koutinas AF, Kanakoudis G, Georgiadis G, Saridomichelakis M. Masticatory and skeletal muscle myositis in canine leishmaniasis (Leishmania infantum). Vet Rec. (2000) 146:698–703. 10.1136/vr.146.24.698 - DOI - PubMed
    1. Torrent E, Leiva M, Segalés J, Franch J, Peña T, Cabrera B, et al. . Myocarditis and generalised vasculitis associated with leishmaniosis in a dog. J Small Anim Pract. (2005) 46:549–52. 10.1111/j.1748-5827.2005.tb00285.x - DOI - PubMed